Cost-Effectiveness Analysis of Motixafortide Versus Plerixafor in Stem Cell Mobilization for Autologous Transplantation in Patients with Multiple Myeloma

被引：1
|
作者：
Lamotte, Mark [1 ]
DiPersio, John F. [2 ]
Siegel, David [3 ]
Meron, Haddas [4 ]
Gerlier, Laetitia [1 ]
机构：
[1] IQVIA, Global HEOR, Zaventem, Belgium
[2] Washington Univ, Div Oncol, Internal Med, Sch Med, St Louis, MO USA
[3] Hackensack Univ, John Theurer Canc Ctr, Div Multiple Myeloma, Med Ctr, Hackensack, NJ USA
[4] ModLineRx, Modiin, Israel
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-166865
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：10794 / 10795
页数：2
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS ANALYSIS OF MOTIXAFORTIDE ON TOP OF G-CSF FOR STEM CELL MOBILIZATION FOR AUTOLOGOUS BONE MARROW TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA
    Lamotte, M.
    DiPersio, J. F.
    Siegel, D. S.
    Meron, H.
    Serlin, P. A.
    Gerlier, L.
    VALUE IN HEALTH, 2022, 25 (07) : S346 - S346
  • [2] Cost-Effectiveness of Hematopoietic Stem Cell Mobilization Strategies Including Plerixafor in Multiple Myeloma and Lymphoma Patients
    Ales, Tichopad
    Veronika, Vitova
    Zdenek, Koristek
    Daniel, Lysak
    JOURNAL OF CLINICAL APHERESIS, 2013, 28 (06) : 395 - 403
  • [3] Safety and Cost-Effectiveness of Outpatient Autologous Stem Cell Transplantation in Patients with Multiple Myeloma
    Holbro, Andreas
    Ahmad, Imran
    Cohen, Sandra
    Roy, Jean
    Lachance, Silvy
    Chagnon, Miguel
    LeBlanc, Richard
    Bernard, Lea
    Busque, Lambert
    Roy, Denis Claude
    Sauvageau, Guy
    Kiss, Thomas L.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (04) : 547 - 551
  • [4] Chemotherapy-based versus chemotherapy-free stem cell mobilization (± plerixafor) in multiple myeloma patients: an Italian cost-effectiveness analysis
    Lazzaro, Carlo
    Castagna, Luca
    Lanza, Francesco
    Laszlo, Daniele
    Milone, Giuseppe
    Pierelli, Luca
    Saccardi, Riccardo
    BONE MARROW TRANSPLANTATION, 2021, 56 (08) : 1876 - 1887
  • [5] Chemotherapy-based versus chemotherapy-free stem cell mobilization (± plerixafor) in multiple myeloma patients: an Italian cost-effectiveness analysis
    Carlo Lazzaro
    Luca Castagna
    Francesco Lanza
    Daniele Laszlo
    Giuseppe Milone
    Luca Pierelli
    Riccardo Saccardi
    Bone Marrow Transplantation, 2021, 56 : 1876 - 1887
  • [6] Preemptive plerixafor based mobilization strategy in multiple myeloma patients for autologous stem cell transplantation
    Vadlamani, Surya Prakash
    Kumar, Lalit
    Pramanik, Raja
    Varshney, Ankur Nandan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E303 - E303
  • [7] COST-EFFECTIVENESS OF EARLY VERSUS DELAYED AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) FOR MULTIPLE MYELOMA (MM)
    Kelkar, Amar
    Midha, Shonali
    Richardson, Paul
    Anderson, Kenneth
    Munshi, Nikhil
    Laubach, Jacob
    Ghobrial, Irene
    Mo, Clifton
    Nadeem, Omar
    Cliff, Edward
    Abel, Gregory
    Soiffer, Robert
    Cutler, Corey
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 107 - 108
  • [8] COST-EFFECTIVENESS OF PLERIXAFOR (PXF) FOR STEM CELL MOBILIZATION IN LYMPHOMA (NHL/HL) AND MULTIPLE MYELOMA (MM) PATIENTS IN POLAND
    Kaczor, M. P.
    Wojcik, R.
    Pawlik, D.
    Glasek, M.
    Pieczonka, A.
    Lis, J.
    VALUE IN HEALTH, 2013, 16 (07) : A384 - A385
  • [9] Multiple Myeloma: Risk Adapted Use of Plerixafor for Stem Cell Mobilization Prior to Autologous Stem Cell Transplantation is Effective and Cost Efficient
    Prakash, Vadlamani Surya
    Malik, Prabhat Singh
    Sahoo, Ranjit Kumar
    Pramanik, Raja
    Choudhary, Priyanshu
    Varshney, Ankur Nandan
    Kumar, Lalit
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (01): : 44 - 51
  • [10] Cost-effectiveness analysis of early vs. late autologous stem cell transplantation in multiple myeloma
    Pandya, Chintan
    Hashmi, Shahrukh
    Khera, Nandita
    Gertz, Morie A.
    Dispenzieri, Angela
    Hogan, William
    Siddiqui, Mustaqeem
    Noyes, Katia
    Kumar, Shaji K.
    CLINICAL TRANSPLANTATION, 2014, 28 (10) : 1084 - 1091
12345